As ALS remains a rare, yet complex disorder with multiple facets of pathogenesis, the potential to cure the disease lies in the continued elucidation of the ncRNA transcriptome which involves the understanding of both miRNA dysregulation and the function of hnRNPs, such as TDP-43. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.